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Abstract
Background. Breast cancer remains the second-leading cause
of cancer death among Canadian women. Treatment for breast
cancer often includes surgery. Many women have a choice
between mastectomy (MT; removal of the entire breast) or breast
conserving surgery (BCS; removal of the tumour and some non-
cancerous breast tissue) followed by radiation. However,
Newfoundland and Labrador consistently has a higher rate of mas-
tectomies than the rest of Canada. In this project, we aim to better
understand that trend.  
Design and methods. A multi-method design was chosen.
Surgical treatment data kept by the province will be examined to
describe the number and types of breast cancer surgeries over
time. Second, we will hold focus groups with women around the
province who have made surgical treatment choices to explore
influences on their decisions. Finally, semi-structured interviews
with breast cancer surgeons and surgical residents will explore
their opinions on surgical treatment choices. 
Expected impact for public health. Cancer treatment choices
are complex decisions, affected by clinical, demographic and
social variables. Understanding why women from Newfoundland
and Labrador have the highest rate of mastectomy in Canada is
critical to ensure they are receiving appropriate screening and
care. Greater understanding of the influences on women’s surgical
choices may encourage informed decisions amongst women and
physicians and promote active communication about treatment,
benefits relevant to all jurisdictions and health authorities. Further,
if factors such as geographic proximity to treatment facilities are
associated with treatment decisions, this information is important
for public health screening and service planners. 
Introduction
Breast cancer remains the most common cancer diagnosed
among Canadian women and the second-leading cause of cancer
death.1 The Canadian Breast Cancer Foundation reports one quar-
ter of new female cancer cases in 2016 was due to breast cancer
(www.cbcf.org). Improvements in breast cancer treatment, howev-
er, suggest that early stage breast cancer has a favourable progno-
sis.1,2 Most women diagnosed with non-metastatic breast cancer
are candidates for surgery, whether breast conserving surgery
(BCS, also known as lumpectomy) followed by radiation therapy,
or mastectomy (MT).1 In BCS, the tumour is removed along with
a margin of non-cancerous breast tissue, while MT involves
removal of the entire breast. BCS is less invasive than MT, asso-
ciated with better psychological outcomes, and if followed by
radiation, has comparable survival.3 Thus, guidelines suggest that
if BCS is not contraindicated on clinical grounds, women with
breast cancer should be offered a choice between BCS and MT.2,4
It might be assumed that eligible women would choose the less
radical BCS. However, breast units worldwide display varying
surgical practice,1 that is not explained by case mix.5 A pan-
Canadian study2 revealed wide inter-provincial variation in surgi-
cal treatment choices. The crude MT rate was 39%, but this varied
from 26% in Quebec to 69% in Newfoundland and Labrador. A
special focus report on breast cancer in Canada1 revealed that
while 80% of breast cancer cases in Canada in 2010 were diag-
nosed with early disease, NL had a higher percentage (27%) diag-
nosed with advanced disease (Stage 3 or 4). It is unlikely, howev-
er, that stage distribution alone accounts for the variation in surgi-
cal management of breast cancer in Canada as there is a fairly
comparable stage distribution across provinces.1,2 A number of
socio-demographic variables influence women’s surgical choices.
For example,  age, income and education have all been associated
with surgical choice, with women of higher income and education
levels more likely to choose BCS.6,7 The literature regarding the
effect of age is mixed, due in part to heterogeneity among studies
in age cutoffs and the year in which studies are conducted.6 It is
suggested that age alone is not a significant predictor of surgical
choice.6 Women’s attitudes and beliefs about cancer recurrence,
chance of survival, body image and sexuality, as well as radiation
therapy have also been associated with cancer surgical decisions.8-
11 Clinical factors such as tumour size and stage,7 geographic area
(rural vs. urban),1 the availability of radiation facilities, and clini-
cian advice also affect women’s surgical decisions.11,12 Canadian
women with longer travel times to a radiation facility were more
likely to undergo MT.2 The recent special focus report on breast
cancer in Canada1 revealed that until travel time exceeds 40 min-
utes, the MT rate is constant, after which it increases by 7%. The
Significance for public health
Cancer treatment choices are complex decisions, affected by numerous clin-
ical, demographic and social variables. Research is needed to understand
why women from Newfoundland and Labrador have the highest rate of mas-
tectomy in Canada. Greater understanding of the influences on women’s sur-
gical choices may help encourage informed decisions amongst women and
physicians and promote active communication about treatment, benefits rel-
evant to all jurisdictions and health authorities. Further, if factors such as
geographic proximity to treatment facilities are associated with treatment
decisions, this information is important for public healthcare spending and
service planners. Finally, it is our hope the findings from this project could
help improve the screening process and surgical care of breast cancer
patients in Newfoundland and Labrador.
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MT rate increases further with additional minutes of travel time. It
is noted that whether these patterns are due to travel-related barri-
ers or other factors associated with rural living is currently
unknown. Finally, an important factor with a strong influence on
women’s treatment choices is the preference of their surgeon or
oncologist.11 This is important in light of recent support for shared
decision-making in healthcare contexts and evidence-informed
patient choice. Specifically, evidence suggests that women whose
preferred level of involvement in treatment decisions is met have
better quality of life and satisfaction with their treatment
decisions.12,13Significance
Greater understanding of the influences on women’s surgical
choices may help encourage informed decisions amongst women
and physicians and promote active communication about treat-
ment. Further, if factors such as geographic proximity to treatment
facilities are associated with treatment decisions, this information
is critical for healthcare spending and service planning. Finally,
given the higher rate of mastectomies in NL breast cancer
patients,2 research is needed to understand this pattern and ensure
care is offered appropriately. Overall study design
We have assembled a research team composed of academic
researchers, epidemiologists, healthcare professionals and (former)
breast cancer patients. In this three-year study, we will use quanti-
tative and qualitative methods to address study objectives and
questions. The study protocol has been approved by the provincial
Health Research Ethics Authority (Reference #2016.023).Key study objectives
To document the number of breast cancer surgeries in NL,
including information on tumor stage (the latter not available in the
recent Canadian report, but known to affect whether BCS or MT is
offered to patients).2
To explore patients’ and surgeons’ perceptions of the factors
influencing the choice of BCS with radiation therapy or MT. Research questions and hypotheses
What is the rate of BCS and MT in NL over a given time period
(the highest quality data is expected to be for the last 5 years)?
Based on the recent Canadian report2, we expect a higher MT rate
compared to BCS. 
What clinical and non-clinical factors are associated with these
rates? (e.g., tumour stage and size, age, rural vs. urban). We
hypothesize that tumour stage and living area will be associated
with surgical treatment, such that a later stage tumour is associated
with MT, as is living a further distance from a radiation facility.  
What factors do patients and surgeons perceive affect surgical
treatment choice in breast cancer? We have no specific hypotheses
for this qualitative item, but suspect clinicians will focus on clini-
cal characteristics of the tumour and chance of survival, while
women will invoke a wider range of influences (e.g., family con-
cerns, cancer fear, body image concerns, etc.).
Materials and MethodsQuantitative 
First, we propose a quantitative, retrospective cohort study
using surgery data maintained in the Discharge Abstract Database
at the Newfoundland and Labrador Centre for Health Information
to describe the rates of BCS and MT in NL. We will extract other
clinical and non-clinical information from the provincial Tumour
Registry (e.g., tumour stage and size, age, living area). Regression
analyses will be used to predict treatment decision (BCS or MT).
Following the recent pan-Canadian study,2 a logistic regression
model can be fit with independent variables such as tumour stage,
age, travel time to nearest radiation facility and other available
tumour and demographic variables. Coefficients derived from the
model will be used to calculate the probability of MT or BCS for
each woman. The expected provincial rate of MT or BCS is based
on the sum of the probabilities of MT or BCS for all women living
in NL. Adjusted rates of MT or BCS can then be calculated as fol-
lows: (crude MT or BCS rate/predicted MT or BCS rate) × the
crude rate for Canada.1,2Qualitative
Semi-structured interviews with surgeons and surgical residents
In parallel to the review of administrative data, we will hold
focus groups with former and current breast cancer patients and
conduct semi-structured interviews with surgeons and residents.
Interviews were chosen with surgeons and residents as it was
thought arranging group discussions would be difficult in light of
varying and busy surgical schedules. Breast surgeons around the
province will be identified through the team’s healthcare contacts,
as well as with the assistance of the Newfoundland and Labrador
Medical Association and/or the College of Physicians and
Surgeons of Newfoundland and Labrador. Eligible surgeons and
residents will be sent a study information invitation letter through
the email/mailing lists of relevant provincial organizations and/or
the Faculty of Medicine at Memorial University. Eligibility criteria
include: 1. Be a practicing general surgeon who performs breast
surgeries in any of the four health regions of the province; 2.Or, be
a general surgical resident at the time of the study recruitment; and
3. Speak English. Through the team’s contacts, we will use snow-
balling recruitment to generate additional names (e.g., we will ask
each surgeon to recommend another to whom a study invite can be
sent). Flexibility in interview scheduling and modality (e.g., tele-
phone, face-to-face, online) will be employed in order to accom-
modate as many surgeons/residents as possible. Our goal is to col-
lect data in each of the province’s four health authorities in order
to include views from all areas of our province. Prior qualitative
research of team members suggests that 15-20 interviews tend to
achieve data saturation (i.e., the point at which no new additional
information arises in interviews). We aim for 15-20 interviews in
total, spread across the health authorities (Table 1). Focus groups with women who have made breast cancer surgical decisions
To recruit women who have made surgical treatment decisions
for breast cancer, we will ask participating surgeons to identify eli-
gible women. Women will be sent a study invite letter and invited
to call the research team if they are interested. We will advertise
the study in newspapers, community cancer organizations (e.g.,
cancer fundraisers such as the provincial Relay for Life), and in
conjunction with the Dr. Bliss Murphy Cancer Centre (e.g., study
ads can be included in mailouts, newsletters, posted at Daffodil
Place and support groups). We aim to conduct focus groups (n=12)
with women from each of the four health authorities. Prior work of
the team (both in breast cancer and other health research) suggests
two focus groups per region (with 5-8 participants) should ensure
data saturation. We plan to hold group sessions in cities and towns
such as the capital city of St. John’s, as well as the towns of Grand
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Falls-Windsor, Gander, Corner Brook and two sites in Labrador.
Team members (in particular Dicks) have previously held focus
groups with breast cancer patients in St. John’s and found them to
be an acceptable way to discuss treatment options and choices,
with six women per group being optimal. Focus groups are also
appropriate when participants share similar experiences and a goal
is to generate understanding of a complex phenomenon at an
affordable cost (Table 2). Qualitative data analysis
In the main, qualitative description14 will be employed to sum-
marize the data pertaining to breast cancer surgical treatment
choices. This form of naturalistic inquiry makes no theoretical
assumptions about the data. Its goal is to present the data in the lan-
guage of participants, without aiming to interpret the data in more
theoretical ways. The end result is a comprehensive summary of
the event in question.15 Qualitative description was a logical
choice for analysing study data as a key goal is to provide a com-
prehensive account of the factors influencing breast cancer surgical
treatment choices from the perspectives of both women and health-
care professionals. Transcripts will be read and re-read several
times by three team members (HE, ED, and RR; the latter two
members have made surgical breast cancer treatment decisions and
will bring that lens to analysis). Interview data will be isolated and
organized around interview topics and utilized to identify and
index emerging categories and themes for particular questions.
These investigators will separately read and re-read the isolated
data, and use the method of constant comparison to inductively
sub-code the data relevant to surgical treatment decisions.14-15
Essentially, data will be compared between and within transcripts
to establish analytical categories and themes,14-15 with a constant
shifting back and forth between and within transcripts to compare
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Table 2. Focus group guide with women who have made surgical treatment choices. 
Themes                                                    Questions and probes for discussion
Family and personal history with cancer            Before your breast cancer, tell me about any prior family history with cancer
                                                                                     (probes – had you ever experienced cancer either yourself or in your family before your diagnosis 
                                                                                     of breast cancer?) 
Initial diagnosis                                                         Tell us about how you were diagnosed with breast cancer. (probes – did you find a lump yourself? 
                                                                                     Did you talk to your family doctor? Were you referred to a surgeon? 
                                                                                     How long were you waiting to see a surgeon)? 
Experience with surgeon                                       What was your experience when you first saw your surgeon? Was a treatment option recommended for you? 
                                                                                     Did you agree with that option? 
Surgical treatment choice                                      How did you make your decision about MT or BCS? (probes: What things did you think about in making 
                                                                                     that decision? What was the most important factor in your decision? Did you have enough time to make your
                                                                                     decision? Are you still satisfied with that decision or was there anything you would have done differently?)
Information needs                                                   How were your information needs met during the surgical decision-making process? 
                                                                                     (probes: Was there information you wanted but did not receive? Did you feel you had enough information 
                                                                                     to make an informed decision about your surgery?)
Advice for other women                                         What advice do you have for other women with breast cancer as they make surgical treatment decisions? 
                                                                                     (probe – is there something you wished you could have had, but didn’t? Is there something that would make
                                                                                     the decision easier?)
Need for education and tools                                Do you think there is any benefit to developing a decision aid or some kind of tool for women to help them 
                                                                                     make choices about surgery related to breast cancer? (probe – what might this tool look like? 
                                                                                     What exactly would be helpful?)
Table 1. Semi-structured interview guide for use with breast cancer surgeons and residents. A recent pan-Canadian study reported that
Newfoundland and Labrador had the highest rates of mastectomies in Canada. 
Themes                                                  Questions and probes for discussion
Comment on statement above                          Does this finding surprise you? (probes – does that correspond with your clinical experience? 
                                                                                  Would you agree with the finding? Why do you think that might be?)
Mastectomy treatment                                        What factors would lead you to recommend mastectomy to a breast cancer patient?
Breast conserving surgical treatment             What factors would lead you to recommend breast conserving surgery instead? 
                                                                                  (Probes – would this always involve radiation therapy as well? Are there non-clinical factors that might 
                                                                                  influence your surgical recommendation?)
Perceptions of women’s surgical choices      Do you think women should be involved in decision making regarding their surgical treatments? If so how?
                                                                                  (probes - Do you think women want to be involved in decision making regarding their surgical treatments?  
                                                                                  If so, to what extent? What do you think of the current recommendation for ‘shared decision-making’ 
                                                                                  among patients and clinicians?)
Reflections on the factors influencing             Which factors do you feel most influence women’s choices about MT or BCS?
women’s surgical choices                                  (probe – do you think there is a most important factor for women in making the decision to undergo MT 
                                                                                  or BCS?)
Need for education and tools                            Do you think there is any benefit to developing a decision aid or some kind of tool for women to help them make
                                                                                  choices about surgery related to breast cancer? (probe – what might this tool look like? 
                                                                                  What exactly would be helpful?)
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the perceptions and experiences of participants. When investiga-
tors complete their separate analyses, they will meet to review and
reach consensus on categories and themes before sharing results
with other members of the team for validation. Ethical issues
Usage of all data held by NLCHI and the NL Tumour Registry
follows strict ethical guidelines regarding linkage, de-identifica-
tion and access. Data will be de-identified, so only provincial-level
data will be reported, with no personal identifiers. The collection
and storage of qualitative data will follow best ethical practices
(e.g., participants will be advised that participation is voluntary
and given a pseudonym in any reports produced from the data).
Breast cancer participants will also be advised that taking part in
the study will in no way affect their healthcare. Further, one of
team members (JC) is an experienced counsellor and will be avail-
able for further discussion with women should distress occur. Engagement of stakeholders/knowledge translation.  
To further engage with stakeholders, we will use town hall
meetings and academic speaking opportunities to present findings.
We will aim to do this before finalizing the summary report of the
study, so as to include any additional comments/discussions from
town halls. Following the town halls, we will finalize the summary
report of the study and provide participants with a copy, and also
make copies of the summary available to the provincial cancer
organizations and treatment centres. We will post a link to the
study summary on both Memorial University’s and provincial
health authorities’ websites. We will contact community organiza-
tions who helped with recruitment and offer to send a copy to their
members. Finally, study findings will be published in academic
journals and presented at relevant conferences. 
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